FUND OVERVIEW
Pacific Bridge NY (PBNY) is a venture fund dedicated to unlocking cross-border biotech value with a particular interest in bridging the divide between Asia and the West. The fund concentrates on opportunities where high-quality global intellectual property can be advanced cost-effectively through carefully crafted clinical development strategies. The firm also seeks to invest in opportunities where we can leverage our connectivity with Asian preclinical and clinical companies and contact research organizations to speed-up and lower the costs of development.
“We focus on improving the drug development landscape by utilizing the best intellectual property, preclinical resources, and clinical execution globally. This brings down costs, increases speed, and improves outcomes.”
Marc S. Appel, Managing Partner